GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediWound Ltd (NAS:MDWD) » Definitions » 12-1 Month Momentum %

MediWound (MediWound) 12-1 Month Momentum % : 69.52% (As of May. 24, 2024)


View and export this data going back to 2014. Start your Free Trial

What is MediWound 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-24), MediWound's 12-1 Month Momentum % is 69.52%.

The industry rank for MediWound's 12-1 Month Momentum % or its related term are showing as below:

MDWD's 12-1 Month Momentum % is ranked better than
90.32% of 1478 companies
in the Biotechnology industry
Industry Median: -27.03 vs MDWD: 69.52

Competitive Comparison of MediWound's 12-1 Month Momentum %

For the Biotechnology subindustry, MediWound's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediWound's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MediWound's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where MediWound's 12-1 Month Momentum % falls into.



MediWound  (NAS:MDWD) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MediWound  (NAS:MDWD) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


MediWound 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of MediWound's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


MediWound (MediWound) Business Description

Traded in Other Exchanges
Address
42 Hayarkon Street, Yavne, ISR, 8122745
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. Its first biopharmaceutical product, NexoBrid removes dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns also referred to as severe burns. NexoBrid is currently in clinical development in North America and is in the process of preparing its Biologics License Application. The company derives its revenue from the United States.